[go: up one dir, main page]

GB1360553A - Chemical compounds suitable for use as x-ray contrast agents - Google Patents

Chemical compounds suitable for use as x-ray contrast agents

Info

Publication number
GB1360553A
GB1360553A GB3340872A GB3340872A GB1360553A GB 1360553 A GB1360553 A GB 1360553A GB 3340872 A GB3340872 A GB 3340872A GB 3340872 A GB3340872 A GB 3340872A GB 1360553 A GB1360553 A GB 1360553A
Authority
GB
United Kingdom
Prior art keywords
ray contrast
chemical compounds
contrast agents
compounds suitable
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3340872A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ERCO LAEKEMEDEL AB
Original Assignee
ERCO LAEKEMEDEL AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ERCO LAEKEMEDEL AB filed Critical ERCO LAEKEMEDEL AB
Publication of GB1360553A publication Critical patent/GB1360553A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1360553 X-ray contrast agent ERCO LAKEMEDEL AB 17 July 1972 [11 Aug 1971] 33408/72 Heading A5B [Also in Division C2] X-ray contrast compositions contain a salt of an acid of formula: wherein acyl represents acetyl or propionyl and X represents a C 3-6 alkylene radical. In Example 2, a compound of the above formula in which acyl is acetyl and X is butylene is mixed with N-methylglucammie, Na-Ca- EDTA, ammonium hydroxide, NaOH and water. The product is suitable for injection.
GB3340872A 1971-08-11 1972-07-17 Chemical compounds suitable for use as x-ray contrast agents Expired GB1360553A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1023171A SE366652B (en) 1971-08-11 1971-08-11

Publications (1)

Publication Number Publication Date
GB1360553A true GB1360553A (en) 1974-07-17

Family

ID=20291955

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3340872A Expired GB1360553A (en) 1971-08-11 1972-07-17 Chemical compounds suitable for use as x-ray contrast agents

Country Status (6)

Country Link
JP (1) JPS4828624A (en)
DE (1) DE2236429A1 (en)
FR (1) FR2150773B1 (en)
GB (1) GB1360553A (en)
IT (1) IT1050455B (en)
SE (1) SE366652B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009106552A3 (en) * 2008-02-27 2010-02-18 Ge Healthcare As Contrast agents
WO2010060941A3 (en) * 2008-11-27 2010-07-29 Ge Healthcare As Contrast agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009106552A3 (en) * 2008-02-27 2010-02-18 Ge Healthcare As Contrast agents
US8535642B2 (en) 2008-02-27 2013-09-17 Ge Healthcare As Contrast agents
WO2010060941A3 (en) * 2008-11-27 2010-07-29 Ge Healthcare As Contrast agents

Also Published As

Publication number Publication date
DE2236429A1 (en) 1973-02-22
IT1050455B (en) 1981-03-10
FR2150773B1 (en) 1976-07-02
JPS4828624A (en) 1973-04-16
SE366652B (en) 1974-05-06
FR2150773A1 (en) 1973-04-13

Similar Documents

Publication Publication Date Title
GB1445407A (en) Photographic materials
GB1402047A (en) Aqueous ink for use in the ink jet process
ES416797A1 (en) Use of perfluoralkylphosphorus compounds as foam-dampening agents
GB1533070A (en) Release agent composition
GB1354571A (en) Amides and their use as insecticides
GB1320032A (en) Imidazole derivatives
ES439148A1 (en) Liquid preparation of fatty acid/alkanolamine condensates
GB1360553A (en) Chemical compounds suitable for use as x-ray contrast agents
GB1416292A (en) X-ray contrast agents their application and a process for their production
GB1197032A (en) The Treatment of Hair
GB1313228A (en) Tri-iodo-benzoic acid derivatives
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
GB1255098A (en) Derivatives of glycyrrhetinic acid
ES427653A1 (en) 3-Hydroxyacyl aminomethyl-5-acylamino-2,4,6-triiodobenzoic acid salts as x-ray contrast agents
GB1459518A (en) Process for the preparation of bicyclo 4,3,0-nonenols
GB1460974A (en)
GB1444696A (en) Esters sitable for use as transparentizing agents
GB1255752A (en) A novel imidazolidin 2-one-1-carboxylic acid amide and its use as a herbicidal agent
GB1421580A (en) Production of benzylamine derivatives
GB1434757A (en) Method and composition for the control of fertility
GB1359908A (en) Water-soluble iodomethane sulphonamide useful as non-ionic x-ray contrast compounds and process for their production
GB1429861A (en) Vincamine derivatives
GB1263677A (en) Process for the preparation of quinoxaline-di-n-oxide-aldehyde
GB1430188A (en) Diaza-oxa-bicyclodecane derivatives
GB1467225A (en) 7-alkoxy-4,6-dihydroxy-quinoline derivatives and pharmaceuti cal compositions thereof

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee